LVW Advisors LLC Grows Stock Position in Zoetis Inc. (NYSE:ZTS)

LVW Advisors LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 30.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,641 shares of the company’s stock after purchasing an additional 380 shares during the quarter. LVW Advisors LLC’s holdings in Zoetis were worth $278,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Roberts Wealth Advisors LLC raised its position in Zoetis by 3.5% in the first quarter. Roberts Wealth Advisors LLC now owns 24,418 shares of the company’s stock worth $4,132,000 after acquiring an additional 816 shares in the last quarter. Koss Olinger Consulting LLC purchased a new position in Zoetis in the first quarter worth $5,022,000. Sandy Cove Advisors LLC raised its position in Zoetis by 7.8% in the first quarter. Sandy Cove Advisors LLC now owns 1,677 shares of the company’s stock worth $284,000 after acquiring an additional 121 shares in the last quarter. Annapolis Financial Services LLC raised its position in Zoetis by 32.4% in the first quarter. Annapolis Financial Services LLC now owns 409 shares of the company’s stock worth $69,000 after acquiring an additional 100 shares in the last quarter. Finally, River Street Advisors LLC raised its position in Zoetis by 15.3% in the first quarter. River Street Advisors LLC now owns 2,025 shares of the company’s stock worth $343,000 after acquiring an additional 268 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on ZTS shares. The Goldman Sachs Group cut their price objective on Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a research report on Monday, May 6th. Barclays lowered their target price on Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 23rd. Stifel Nicolaus lowered their target price on Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Piper Sandler reissued an “overweight” rating and issued a $195.00 target price (down previously from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. Finally, HSBC decreased their price objective on Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Zoetis has an average rating of “Buy” and a consensus price target of $211.75.

Zoetis Stock Performance

NYSE ZTS opened at $173.36 on Monday. The business’s 50-day moving average price is $168.69 and its 200 day moving average price is $178.59. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The company has a market capitalization of $79.10 billion, a PE ratio of 33.40, a price-to-earnings-growth ratio of 2.69 and a beta of 0.86. The company has a current ratio of 3.33, a quick ratio of 1.94 and a debt-to-equity ratio of 1.30.

Zoetis (NYSE:ZTS) last released its earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.04. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The firm had revenue of $2.19 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, research analysts predict that Zoetis Inc. will post 5.76 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be given a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, July 18th. This represents a $1.73 annualized dividend and a yield of 1.00%. Zoetis’s dividend payout ratio (DPR) is presently 33.33%.

Insider Buying and Selling

In other news, EVP Roxanne Lagano sold 923 shares of the firm’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $151.17, for a total value of $139,529.91. Following the transaction, the executive vice president now directly owns 14,800 shares in the company, valued at approximately $2,237,316. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.16% of the stock is currently owned by company insiders.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.